作者: Victoria A. Komater , Kaitlin E. Browman , Peter Curzon , Arthur A. Hancock , Michael W. Decker
DOI: 10.1007/S00213-003-1431-0
关键词:
摘要: Rationale Attention deficit hyperactivity disorder (ADHD) is currently treated with psychomotor stimulants, including methylphenidate and amphetamine. Several adverse effects are associated these drugs, however, such as agitation abuse. H3 receptor antagonists under clinical investigation for ADHD.